Pharma News

Scientists have developed a pill that could significantly improve the imaging techniques involved in breast cancer and can better help in the diagnosis of the deadly disease  the second most common cancer in women.

[adsense:336x280:8701650588]

A weak ecosystem of bacteria in human gut due to a poor dietary diversity is likely to trigger diseases like Type 2 diabetes and obesity, finds new research, suggesting people to eat a balanced, diversed diet.

Using stem cells derived from human skin cells, US researchers have revealed that these can be turned into retinal ganglion cells (RGCs) the neurons that conduct visual information from the eye to the brain to prevent or cure glaucoma.

A team of US researchers has developed a new imaging technique for viewing cells and tissues in three dimensions under the skin, which may one day allow doctors to evaluate how cancer cells are responding to treatment.

A new technique developed by a team of chemists at Stanford University has shown promise to be thousands of times more sensitive than current techniques to diagnose diseases whether it is a cancer or a virus like HIV.

Paracetamol, a medication widely used to treat pain and fever, does not meet the minimum standard of clinical effectiveness in reducing pain or improving physical function in patients with knee and hip osteoarthritis, says a study.

Treating patients with a rare genetic form of diabetes with therapies designed to treat other more common forms of the disease may do more harm than good, warn researches.

In a major advancement towards an effective treatment of Alzheimer's disease, Swiss scientists have developed an implantable capsule that can turn the patient's immune system against the disease.

With a surge in deaths due to dearth of bone marrow donors, health experts have suggested that patients with blood cancer can prefer haploidentical stem cell transplantation, a new procedure that does not need complete match of donors tissues.

Biopharma major Biocon on Thursday announced that its subsidiary was tying up with a Mexican firm to co-develop generic recombinant human insulin for the US market.